Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02486562 · ClinicalTrials.gov registry record

IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis

A clinical trial of Multiple Sclerosis, sponsored by Accelerated Cure Project for Multiple Sclerosis.

Recruiting
Registry status
20,000
Enrollment target
1
Study location

NCT02486562 is a study of Multiple Sclerosis that is actively recruiting participants, run by Accelerated Cure Project for Multiple Sclerosis. The registered enrollment target is 20,000 participants, above the 522-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (3731% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02486562, a study of Multiple Sclerosis, is actively recruiting participants, sponsored by Accelerated Cure Project for Multiple Sclerosis.

RECRUITING
Registry status
20,000 participants
Enrollment target
1
Study location

Study Summary

iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their family members (via iConquerMS Kids \& Teens) and MS caregivers (via iConquerMS Caregivers) to participate.

Conditions Studied

Study Locations (1)

Massachusetts

  • Accelerated Cure Project - Waltham

Trial Details

FieldValue
Enrollment Target 20,000 participants
Start Date 2014-11
Est. Completion 2036-10

What the Registry Record Tells You About NCT02486562

The ClinicalTrials.gov registry entry for NCT02486562 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 522-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (3731% higher). The listed sponsor is Accelerated Cure Project for Multiple Sclerosis, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT02486562 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02486562 about?

NCT02486562 is a clinical study titled "IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis". iConquerMS™ is a research initiative developed by and for people with multiple sclerosis (MS) to contribute their health data and ideas to advance and accelerate research into MS. iConquerMS welcomes adults with MS and others interested in advancing MS research, children and teens with MS and their ...

What is the current status of trial NCT02486562?

This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2014-11. Estimated completion is 2036-10.

What conditions does trial NCT02486562 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

Who is sponsoring clinical trial NCT02486562?

This trial is sponsored by Accelerated Cure Project for Multiple Sclerosis, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02486562 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.